Oxurion’s Perspectives Magazine 2019 is here! Discover last year’s highlights, insights and milestones through inspiring interviews and testimonials by Sehnaz Karadeniz, R.O. Schlingemann, Alan Stitt and many others.
A year full of milestones
2018 was a year to be proud of. We launched four new clinical trials and are ready to publish some initial results in the coming months. Just a few weeks ago, for example, we announced the full enrollment of the Phase 2 trial in anti-PlGF (THR-317) and anti-VEGF for treating DME.
We’re looking forward to the rest of our journey 2019, in which our ambitions will become more and more tangible. – Patrick De Haes, M.D, CEO at Oxurion & Thomas Clay, Chairman of the board.
Discover our stories
We want to share our stories and progressions with everyone in our network, that’s why we’ve collected a series of inspiring interviews, reports and testimonials in our annual magazine: Perspectives.Read Perspectives magazine online
This magazine reflects our efforts and features our partners, NGO’s, patient organizations, our own team members and professionals from the eye community.